|
|
|
|
|
|
|
|
|
Webinar: Evaluating Modular CAR T Manufacturing Workflows: Performance, Flexibility, and Scale
|
Join this webinar to explore how modular workflows can help CAR T developers increase manufacturing flexibility, throughput, and scalability while maintaining critical cell quality attributes. Review comparative data across activation, transduction, phenotype, and cell isolation, and learn how modular strategies can enable parallel processing, reduce bottlenecks, and support evolving manufacturing requirements from process development through commercial production. Click here to learn more.
|
|
|
|
|
|
Video | Lonza
|
Explore end-to-end capabilities in cell and gene therapy, mRNA, and microbial platforms, emphasizing scalability, innovation, and seamless development through commercial manufacturing.
|
|
|
|
|
|
Video | Invetech
|
Review this third-generation automated bag filling platform designed to improve precision, consistency, and control for reliable GMP manufacturing
|
|
|
|
|
|
Webinar | Thermo Fisher Scientific
|
See how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.
|
|
|
|
|
|
Video | Charter Medical
|
Learn how single-use manifolds can optimize your biomanufacturing processes, reducing time, space, and resources while increasing flexibility, product quality, and scalability.
|
|
|
|
|
|
Webinar | MaxCyte, Inc.
|
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
|
|
|
|
|
|
Video | Cell & Gene
|
In this segment of Cell & Gene Live, Miguel Forte, M.D., Ph.D., CEO and Co-Founder, Kiji Therapeutics, Michael Schuster, Director of Business Development, Mesoblast, and Edward Ahn, Ph.D., CEO and Director, MEDIPOST Inc., cover realistic applications for AI and automation in process development, visual inspection, data analysis, root-cause analysis, and comparability.
|
|
|
|
|
|
Webinar | Artis BioSolutions
|
View a scalable, open-access AAV9 manufacturing process improving yield, purity, and consistency through optimized transfection and downstream purification for clinical-grade gene therapy production.
|
|
|
|
|
|
|
|
|
|
|
Autologous CAR T-cell therapy offers enormous potential, but patient-specific manufacturing presents challenges in turnaround time, quality, scalability, and technology transfer. In this Cell & Gene Live on Oct. 15, 2026 at 11 AM ET, Mayo Clinic experts will share practical insights on overcoming production bottlenecks, strengthening quality-focused processes, partnering with CDMOs, evaluating alternative platforms, and making early CMC decisions that support clinical execution and commercial readiness. Registration is free.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
|
|
